For most medical device manufacturers, this is not an unusual scenario. It is a routine one.

Stanford's Dr. Perez shows Apple Watches detect AFib with 86% accuracy, offering accessible cardiac monitoring as 115M ...

Kezar Life Sciences is a biotech, not a medical device company, but the mechanics work the same way for any company with a ...

UCLA and North Texas cardiologists debate universal AFib monitoring at HRS 2026, with concerns over data overload vs. disease ...

At HRS 2026, Dr. Song Zuo presented evidence that AI can detect atrial fibrillation with over 90% sensitivity, ...

Pulse Biosciences is positioning its nanosecond PFA technology as a game-changer in the competitive atrial fibrillation ...

After a shove from European Parliament, EU member states, and industry stakeholders, the European Commission (EC) issued ...

Verve Medical's renal pelvic denervation therapy leverages location to deliver a targeted, minimally invasive treatment for ...

Vida Health partnered with Oura to integrate real-time biometric data from the Oura Ring into virtual cardiometabolic care ...

MD+DI Senior Editor Amanda Pedersen weighs in on the latest politicized policies proposed by the HHS Secretary Robert F.

Boston Scientific faces securities fraud lawsuit alleging withheld info on declining EP market share, unsustainable growth, ...

The catheter market size was estimated at $61.89 billion in 2025 and is expected to reach about $103.91 billion by 2033 with ...